Patents
Patents for C07C 219 - Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton (3,521)
12/2002
12/04/2002CN1382684A Method for preparing methacrylic acid [2-(bismuth dimethyl)-1-(bismuth dimethyl methyl) ethyl] ester
11/2002
11/27/2002EP1259477A1 Aminoadamantane derivatives as therapeutic agents
11/20/2002EP1017925B1 Method and compound for inhibiting the plugging of conduits by gas hydrates
11/14/2002US20020169208 Oxybutynin analogs; antichloinergic agents; side effect reduction; short half-life; water-soluble metabolites; incontinence; mydriatic and bronchodilator agents; respiratory system disorders; antiperspirants
11/13/2002EP0843672B1 One pot synthesis of 2-oxazolidinone derivatives
11/12/2002US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/07/2002WO2001047866A9 Substituted 1 and 2 naphthol mannich bases
11/07/2002US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/06/2002EP1254891A1 Process of fabrication of 2-(dimethylamino)-1-(dimethylaminomethyl)ethyl-(methyl)acrylate
11/06/2002EP1254890A1 Derivatives of 3,3-diphenylpropylamines
11/06/2002CN1377876A Process for preparing benzoxy -2-[[1-methyl-2-[3-(trifluoromethyl)-phenyl]ethyl]amino] carbethoxy hydrochloride
11/05/2002US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
10/2002
10/30/2002EP1253138A2 Novel tertiary amine compounds having an ester structure and processes for preparing same
10/30/2002EP1253137A1 Process for the production of 1,3-bis(dimethylbenzylammonium)isopropyl acrylate chloride alone or as a mixture with othercopolymers and monomers
10/30/2002EP1253136A1 Process for the production of aqueous solutions of unsaturated quaternary ammonium salts
10/30/2002EP1252135A2 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use
10/30/2002EP1252133A2 Pharmaceutical compounds
10/23/2002EP1251120A1 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl
10/22/2002US6469204 Acrylates comprising several quaternary amino groups in the alcohol part, their process of manufacture and the (co) polymers obtained from these monomers
10/22/2002CA2290409C Softener active derived from acylated triethanolamine
10/16/2002CN1092657C One pot synthesis of 2-oxazolidinone derivatives
10/15/2002US6465419 Esters derived from alkanolamines, dicarboxylic acids and fatty alcohols and the cationic surfactants obtainable therefrom
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/03/2002US20020143056 As inactivator of antigen- specific T cells is useful in the prophylaxis or therapy of autoimmune diseases, disorders involving an autoimmune component or neoplastic diseases
10/02/2002EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/2002
09/25/2002CN1091438C 0-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as method of preparing them
09/24/2002US6455585 Have a higher analgesic activity, a lower toxicity and a longer effective time period than tramadol.
09/24/2002US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/19/2002WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes
09/17/2002US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002CA2122036C Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form
09/11/2002EP0769942B1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
09/11/2002EP0748799B1 Process for producing 5,7-dichloro-4-hydroxyquinoline
09/11/2002CN1090637C Cross-link cinnamic acid derivative and its preparation method
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/03/2002US6444702 Central nervous system disorders
08/2002
08/29/2002WO2001012584A3 Pharmaceutical compounds
08/29/2002US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/28/2002EP0729344B1 Active substance delivery system
08/28/2002CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
08/22/2002US20020115743 Dental materials with extendable work time, kits, and methods
08/21/2002CN1365352A Novel monomers with quaternary amino groups, method for making same, and novel (co) polymers obtained from said novel monomers
08/21/2002CN1365351A Method for making monomers with two quaternary amino groups and (co) polymers obtained from said monomers
08/20/2002US6437173 Process for the continuous manufacturing of dialkylaminoalkyl (METH) acrylates having a critical order of steps
08/15/2002WO2002062815A1 Hybrid protecting groups
08/14/2002EP1230209A2 Stable salts of novel derivatives of 3,3-diphenylpropylamines
08/14/2002EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/08/2002DE10105077A1 Hybrid-Schutzgruppe Hybrid-protecting group
08/07/2002EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
08/01/2002WO2002059074A1 Benzylamine analogue
08/01/2002US20020103331 Reacting N,N-dimethylaminoethyl acrylate (ADAME) with the quaternizing agent CH3Cl in the presence of water, conducted in a closed reactor containing all of the ADAME and having been pressurized with air or with depleted air
08/01/2002CA2435883A1 Benzylamine analogue
07/2002
07/31/2002EP1227095A2 A process for the purification of (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5yl)-methyl)-2-oxazolidinone
07/25/2002DE10127938A1 Production of basic dialkylaminoethyl(meth)acrylates, useful for production of (co)polymers for paints, dispersion or adhesives comprises esterification of (meth)acrylic acid alkyl esters.
07/23/2002US6423855 Prevention lysis; oxidation resistance
07/11/2002US20020091284 Novel acrylates comprising several quaternary amino groups in the alcohol part, their process of manufacture and the (co) polymers obtained from these monomers
07/10/2002CN1358178A Pharmaceutical compounds
07/10/2002CN1087293C New amino alcohol derivatives, process for production thereof and medicaments and reagents containing these compounds
07/09/2002US6417392 Method for production of alkylamino(Meth)acrylate and apparatus therefor
07/09/2002US6416921 Forming non-spherical toner particles using limited coalescense; improved transfer and cleaning efficiency
07/04/2002WO2002034710A3 Novel intermediates for use in retinoid synthesis
07/04/2002US20020086884 Anticancer agents based on regulation of protein prenylation
07/03/2002EP1219623A1 New esters derived from substituted phenyl-cyclohexyl compounds
07/03/2002EP1219594A1 New esters derived from substituted phenyl-cyclohexyl compounds
07/03/2002EP1218336A2 Melanin concentrating hormone antagonist
07/03/2002EP1077912B1 Novel derivatives of 3,3-diphenylpropylamines
07/03/2002CN1356981A Pharmaceutical compounds
07/02/2002US6414170 Preparation of cationic surfactants containing ester group in molecules
06/2002
06/27/2002WO2002014258A3 Method for making aqueous solutions of (meth)acryloyloxyethylbenzyldimethylammonium chlorides
06/19/2002CN1354741A Esterquats, their intermediates, process to make esterquats, and thir use
06/19/2002CN1354740A Pharmaceutical compounds
06/19/2002CN1354737A Novel derivatives of 3-3-diphenylpropylamines
06/18/2002US6407107 4-(morpholino)alkyl butanamide derivatives; autoimmune diseases; anticarcinogenic agents
06/06/2002DE10055554A1 Esterquats Esterquats
06/04/2002CA2095495C Assay for serum cholinesterase
05/2002
05/29/2002DE10127941A1 Production of (meth)acrylate esters by transesterification comprises recycling by-product alcohol to the production of the starting (meth)acrylate
05/29/2002DE10127939A1 Production of (meth)acrylate esters, e.g. dialkylaminoethyl (meth)acrylates, by catalytic transesterification involves four-stage distillation
05/29/2002CN1351007A Acrylate containing multiple quaternary ammonium groups, preparation thereof and its (co)polymer
05/29/2002CN1085724C Process for making solid compositions containing quaternary ester ammonium compounds and fatty acids
05/21/2002US6392104 Chemical intermediates for drugs, agriculture
05/15/2002EP1205470A2 Esterquats
05/08/2002CN1347922A Method for raising molecular weight of acrylyl oxy-ethyl-trimethyl salmiac cation copolymer and relative copolymer
05/02/2002WO2002034710A2 Novel intermediates for use in retinoid synthesis
05/02/2002WO2002034247A2 Anticancer agents based on regulation of protein prenylation
05/02/2002EP1201645A2 Acrylates having several quaternary amino groups in the alcohol moiety, process for their preparation and (co)polymers obtained from these monomers
05/02/2002DE10049481A1 Substituierte C-Cyclohexylmethylamin-Derivate C-substituted derivatives cyclohexylmethylamine
05/02/2002CA2426203A1 Anticancer agents based on regulation of protein prenylation
04/2002
04/30/2002US6379294 Process for preparing esterquats
04/24/2002EP1198449A1 Process for preparing esterquats
04/24/2002CN1346395A Cationic gamini and related multiple hydrophilic/hydrophobic functional compounds and their use as surfactants
04/23/2002US6376703 Method for handling alkylamino (meth) acrylate and apparatus for storage
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 36